Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE (ABBV)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales22 81925 56028 21632 92234 59136 795
EBITDA10 34911 25112 45215 30217 03018 306
Operating profit (EBIT)9 93210 82612 02714 38416 02917 508
Pre-Tax Profit (EBT)6 6457 8847 72711 97513 861-
Net income5 1445 9535 30910 78911 67512 937
P/E ratio18,917,329,314,513,011,8
EPS ( $ )3,133,633,306,887,688,45
Dividend per Share ( $ )2,102,352,563,594,034,39
Yield3,54%3,75%2,65%3,60%4,05%4,41%
Reference price ( $ )59.2462.6296.7199.5799.5799.57
Announcement Date01/29/2016
12:48pm
01/27/2017
12:48pm
01/26/2018
12:51pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt23 26430 41927 57928 63623 57318 058
Finance------
Operating income (EBITDA)10 34911 25112 45215 30217 03018 306
Leverage
(Debt/EBITDA)
2,25x2,70x2,21x1,87x1,38x0,99x
Capital Expenditure532479529699712713
Book Value Per Share (BVPS)2,45 $2,91 $3,20 $1,98 $3,31 $7,86 $
Cash Flow per Share4,58 $4,32 $6,21 $7,71 $8,72 $9,80 $
Announcement Date01/29/2016
12:48pm
01/27/2017
12:48pm
01/26/2018
12:51pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 158 006 M$ -
Entreprise Value (EV) 186 642 M$ 181 579 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 14,5x 13,0x
Capitalization / Revenue 4,80x 4,57x
EV / Revenue 5,67x 5,25x
EV / EBITDA 12,2x 10,7x
Yield (DPS / Price) 3,60% 4,05%
Price to book (Price / BVPS) 50,4x 30,1x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 43,7% 46,3%
operating Leverage (Delta EBIT / Delta Sales) 1,18x 2,26x
Net Margin (Net Profit / Revenue) 32,8% 33,8%
ROA (Net Profit / Asset) 19,5% 21,4%
ROE (Net Profit / Equities) 290% 202%
Rate of Dividend 52,2% 52,4%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   2,12% 2,06%
Cash Flow / Sales 37,2% 40,0%
Capital Intensity (Assets / Sales) 1,68x 1,58x
Financial Leverage (Net Debt / EBITDA) 1,87x 1,38x
EPS & Dividend